APA

Schendel D. J., Frankenberger B., Jantzer P., Cayeux S., Nöbetaner E., Willimsky G., Maget B., Pohla H. & Blankenstein T. (20010405). Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse. : Gene therapy.

Chicago

Schendel D J, Frankenberger B, Jantzer P, Cayeux S, Nöbetaner E, Willimsky G, Maget B, Pohla H and Blankenstein T. 20010405. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse. : Gene therapy.

Harvard

Schendel D. J., Frankenberger B., Jantzer P., Cayeux S., Nöbetaner E., Willimsky G., Maget B., Pohla H. and Blankenstein T. (20010405). Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse. : Gene therapy.

MLA

Schendel D J, Frankenberger B, Jantzer P, Cayeux S, Nöbetaner E, Willimsky G, Maget B, Pohla H and Blankenstein T. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse. : Gene therapy. 20010405.